1-4 of 4
Kerem Ar, MS
Close
Sort by
Journal Articles

Identification of Novel Cluster Groups in High-Risk Pediatric B-Precursor Acute Lymphoblastic Leukemia (HR-ALL) by Gene Expression Profiling: Correlation with Clinical and Outcome Variables. a Children’s Oncology Group (COG) Study.

Richard C. Harvey, PhD, I-Ming Chen, MS, Kerem Ar, MS, Stephen P. Hunger, MD, Mignon Loh, MD, Eric C. Larsen, MD, Meenakshi Devidas, PhD, Elizabeth Raetz, MD, Gregory Reaman, MD, William L. Carroll, MD, Naomi Winick, MD, Malcolm Smith, MD, PhD, Kevin K Dobbin, PhD, Cheryl L. Willman, MD
Journal: Blood
Blood (2008) 112 (11): 2256.
https://doi.org/10.1182/blood.V112.11.2256.2256
Published: 2008
Journal Articles

Expression of Midkine(MDK) and Sensitivity to Anti-Leukemic Drugs in Pediatric Acute Lymphoblastic Leukemia (ALL).

Weihua Zeng, PhD, I-Ming Chen, DVM, Justin Tibbitts, MS, Huining Kang, PhD, Kerem Ar, MS, Susan Atlas, PhD, Cheryl L. Willman, MD
Journal: Blood
Blood (2007) 110 (11): 1432.
https://doi.org/10.1182/blood.V110.11.1432.1432
Published: 2007
Journal Articles

Hematopoietic Cell Expression of OPAL1, an Outcome Predictor in Pediatric Acute Lymphoblastic Leukemia.

Weihua Zeng, PhD, I.-Ming Chen, DVM, Yuexian Xu, MS, Jeff Potter, MS, Kerem Ar, MS, Huining Kang, PhD, Cheryl L. Willman, MD
Journal: Blood
Blood (2005) 106 (11): 1457.
https://doi.org/10.1182/blood.V106.11.1457.1457
Published: 2005
Journal Articles

A Gene Expression Classifier for Improved Risk Classification and Outcome Prediction in Pediatric Acute Lymphoblastic Leukemia (ALL).

Cheryl L. Willman, MD, Huining Kang, PhD, Jeffrey W. Potter, MS, Richard C. Harvey, PhD, Susan R. Atlas, PhD, Ed Bedrick, PhD, Paul Helman, PhD, Robert L. Veroff, PhD, I.-Ming Chen, DVM, Andrew J. Carroll, PhD, Kerem Ar, MS, Yuexian Xu, MSD, Sharon B. Murphy, MD, Deepa Bhojwani, MD, Naomi Moskowitz, William L. Carroll, MD, Bruce Camitta, MD
Journal: Blood
Blood (2005) 106 (11): 762.
https://doi.org/10.1182/blood.V106.11.762.762
Published: 2005